+1 508 630 2180
Chief Research Accelerator
Hampus Hillerstrom is President and CEO of LuMind RDS Foundation since September 2017, after serving on the board of directors for three years, including one year as Vice-Chair. Previously, he co‐founded Proclara Biosciences in 2007, a company developing a novel approach for treating Alzheimer’s, Parkinson’s and other protein misfolding diseases, and, he served as Executive Vice President and Chief Financial Officer prior to joining LuMind RDS as CEO.
Previously, he spent three years as an associate at leading European biotech venture capital firm HealthCap where he participated in a large number of investment transactions including several IPOs. Hampus also spearheaded a project at AstraZeneca to evaluate decision‐making leading to Phase III clinical trials and worked on the pharmaceutical industry at investment bank Lazard.
Hampus holds a Masters in Economics and Finance from the University of St. Gallen (Switzerland), an MBA from Harvard Business School, and an MSc in Health Sciences and Technology from MIT/Harvard Medical School (HST). Hampus and his wife are raising sons Oskar, the oldest who has Down Syndrome, and his partner in mischief Sebastian.
In addition to his focus on research, Hampus and his wife are big proponents in their community for early intervention therapies and meaningful inclusion in school. Having grown up in the Swiss Alps, Hampus is an avid skier and also a golfer. Hampus and his wife are cooking and hosting aficionados.